Work

Stability of fetal hemoglobin levels in patients receiving metformin therapy

Year: 2018

Type: article

Abstract: Recently, in vitro studies using progenitor-derived erythroid cells from normal individuals or sickle cell disease (SCD) patients, have identified metformin, an oral hypoglycemic drug, as a promising agent to increase fetal hemoglobin (HbF) levels.[1][1]–[3][2] The mechanisms through which

Source: Haematologica

DOI: 10.3324/haematol.2018.190967

Authors: Mohamed-Rachid Boulassel, Abdal-Aziz Issa El-Hussain, Moataz Mohamed Hassan, Mohamed-Lamine Toumi, Sameha Merzoug, Zahra Al-Qarni, Hammad Khan, Zied Gaifer, Khalil Al-Farsi, Murtadha Al-Khabori, Mohamed Al Huneini, Salam Al-Kindi

Institutions: Sultan Qaboos University Hospital, Sultan Qaboos University, Chadli Bendjedid El Tarf University

Language: English

Topic: Hemoglobinopathies and Related Disorders

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,157

Funder: Sultan Qaboos University

Award: G2044406344

OpenAlex ID: W2802369583

FWCI: 0.655

Cites: 9

Cited by: 5

Related to: 10